However, it is unknown at present if the functions of these cells can be enhanced by simply increasing their (1) glycolysis, (2) activation of the Akt-mTORC1 pathway, or (3) their ability to compete for glucose in the tumor microenvironment. This evidence concerns the gene AKT1 and neoplasm.